SO WHAT: If you purchased Teladoc stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving a ...

Shareholders who purchased shares of TDOC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: November 2, 2022 to February 20, 2024 WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The ...

文章核心观点 - 泰拉多克健康公司(Teladoc Health, Inc.)被指控存在证券欺诈行为,导致投资者遭受损失 [1][2][3] - 公司在2023年第四季度和全年业绩公告中披露增长低于预期,BetterHelp在线咨询服务的收入也出现下降 [3] - 分析师认为BetterHelp的市场饱和和广告成本上升导致客户获取成本上升,是造成收入下降的主要原因 [3] 根据相关目录分别进行总结 公司概况 - 泰拉多克健康公司是一家提供远程医疗服务的公司,在线上提供医疗咨询等服务 [1][2][3] 诉讼情况 - 公司被指控存在证券欺诈行为,导致投资者遭受损失 [1][2] - 投资者可以在2024年7月16日之前申请成为集体诉讼的代表原告 [4] - 如果成为集体诉讼成员,可以获得赔偿而无需支付任何费用 [5] 律所介绍 - 莱维和科斯金斯律所在过去20年中为受害股东赢得了数亿美元的赔偿,在复杂的证券诉讼中拥有丰富的经验 [6] - 该律所连续7年被评为美国前50大证券诉讼律所之一 [6]

NEW YORK, June 11, 2024 /PRNewswire/ -- WHAT TO DO NEXT: To join the Teladoc class action, go to https://rosenlegal.com/submit-form/? case_id=6818 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 16, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigatio ...

Analysts and investors alike will be keeping a close eye on the performance of Teladoc in its upcoming earnings disclosure. The company is expected to report EPS of -$0.35, up 12.5% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $649.84 million, reflecting a 0.39% fall from the equivalent quarter last year. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by thir ...

PURCHASE, NY, June 10, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced that its Board of Directors has appointed Charles "Chuck" Divita, III, as Chief Executive Officer, effective immediately. Concurrent with his role as CEO, Mr. Divita has also joined Teladoc Health's Board of Directors as of today. "I'm honored and grateful to the Board for this opportunity," said Divita. "Teladoc Health has been successful at securing a leading p ...

文章核心观点 - 泰拉多克健康公司(Teladoc Health)任命查尔斯·迪维塔(Charles "Chuck" Divita, III)为新任首席执行官,接替临时CEO玛拉·穆尔西[1][2][3] - 迪维塔此前在GuideWell担任商业市场执行副总裁,负责230亿美元的收入,在医疗保健行业有丰富的从业经验[2] - 泰拉多克健康董事会认为迪维塔是一位创新和有远见的领导者,能够推动公司的长期可持续发展[3] 公司概况 - 泰拉多克健康是全球领先的整体虚拟医疗服务提供商,利用自有的健康信号和个性化互动来提高患者的健康水平[4] - 公司拥有20多年的专业经验和数据驱动的洞见,以满足消费者和医疗专业人士日益增长的虚拟医疗需求[4] 新任CEO简介 - 迪维塔此前在GuideWell担任商业市场执行副总裁,负责230亿美元的收入,在医疗保健行业有丰富的从业经验[2] - 在此之前,他还曾担任FPIC保险集团的首席财务官[3] - 迪维塔还在Prime Therapeutics、Availity和Vim等公司的董事会任职,并参与了一些社区服务活动[3] - 他是注册会计师,是佛罗里达州注册会计师协会(FICPA)的成员[3] 新任CEO的任命及薪酬 - 迪维塔于2024年6月10日正式就任泰拉多克健康CEO[1][5] - 作为就任CEO的一部分,迪维塔获得了469,924股限制性股票单位和939,849股绩效股票单位[5][6] - 限制性股票单位将在3年内分三次解锁,绩效股票单位的解锁与2025年调整后EBITDA和2025-2027年复合年收入增长率挂钩[5][6]

CONTACT US HERE: CLASS PERIOD: November 2, 2022 to February 20, 2024 DEADLINE: July 16, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/teladoc-health-inc-loss-submission-form-2/? id=83236&from=4 WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business p ...

The Allegations: Robbins LLP is Investigating Allegations that Teladoc Health, Co. (TDOC) Misled Investors Regarding its Marketing Spend and its Impact on Revenue According to the complaint, on February 20, 2024, Teladoc released Q4-2024 earnings. In the Form 10-K filed with the SEC, Teladoc revealed its substantially increased advertising costs, which was $668,854,000 up from $623,536,000 in 2022, while the associated investor presentation revealed BetterHelp revenue fell $1 million compared to the prior y ...

LOS ANGELES, June 07, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC) investors that a class action has been filed on behalf of investors. Teladoc investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw ...